Seroprevalence of immunoglobulin G and E among out-patients with malaria in Ikorodu LGA, Lagos, Nigeria

Uche Igbasi; Wellington Oyibo

doi:10.54034/mic.e1376

Authors

Uche Igbasi Nigerian Institute of Medical Research, 6 Edmund Crescent, Yaba - Lagos, Nigeria
Wellington Oyibo University of Lagos, Lagos, Nigeria https://orcid.org/0000-0002-5730-5396

DOI:

https://doi.org/10.54034/mic.e1376

Keywords:

malaria, immunoglobulin G, immunoglobulin E, immune response

Abstract

Background. Global response to malaria has stalled, despite increased malaria control efforts worldwide. Antibodies are among the immune factors that play a role in mediating protection in malaria, although the mechanism remain unclear. The study evaluated profile of total immunoglobulin G (IgG) and E (IgE) among malaria cases. Methods: A hospital based cross-sectional survey of individuals that presented with malaria symptoms and assessed diagnostic care at selected health facilities in Ikorodu Local Government Area (LGA) of Lagos State, Nigeria. Demographic information was recorded using structured questionnaire. Malaria diagnosis was done by microscopy, ELISA was used to evaluate plasma IgG and IgE profiles among malaria positive and control group. Data was analyzed using SPSS version 23. Results: LgE plasma level (34760.63±2954.5 pg/ml, p=0.005) was significantly higher in malaria positive cases compared with negative control group (19912.12± 6762.6pg/ml, p<0.01). In contrast, no significant difference between IgG levels in malaria positive (4936.53±211.4 pg/ml) and negative cases (4861.64 498.8pg/ml; p =0.297). Age and IgG profile correlated (r = 0.192; p = 0.010); and negative correlation between IgE profile and age although not significant (r= -0.008; p= 0.911). LgE correlated negatively with parasite density, although not significant (r = -0.019; p =0.833). IgG levels correlated with PCV (r =-0.27; p = 0.001), while IgE did not correlate. Conclusion: This study demonstrated increased IgE in uncomplicated malaria cases, and suggests that malaria could be a key differential diagnosis in acutely febrile patients with abnormally elevated IgE levels in malaria endemic area.

References

WHO. World Malaria report. 2021. World Health Organization; 2021.

Schofield L. Intravascular infiltrates and organ-specific inflammation in malaria pathogenesis. Immunol. Cell Biol. 2007; 85: 130-137.

Rogerson SJ, Wijesinghe RS, Meshnick SR. Host immunity as a determinant of treatment outcome in Plasmodium falciparum malaria. Lancet Infect. Dis. 2010; 10(1): 51-59

Plebanski M, Hill AV. The immunology of malaria infection. Curr. Opin. Immunol. 2000; 12(4):437- 41.

Aponte JJ, Menendez C, Schellenberg D, Kahigwa E, Mshinda H, Vountasou P, et al. Age interactions in the development of naturally acquired immunity to Plasmodium falciparum and its clinical presentation. PLoS Med. 2007; 4: e242.

Ghani AC, Sutherland CJ, Riley EM, Drakeley CJ, Grifn JT, Gosling RD, et al. Loss of population levels of immunity to malaria as a result of exposurereducing interventions: consequences for interpretation of disease trends. PLoS ONE. 2009;4: e4383.

Druilhe PI, Pradier O, Marc JP, Miltgen F, Mazier D, Parent G. Levels of antibodies to Plasmodium falciparum sporozoite surface antigens reflect malaria transmission rates and are persistent in the absence of reinfection. Infect Immun. 1986; 53(2):393-7.

Duarte J, Herbert F, Guiyedi V, Franetich JF, Roland J, Cazenave PA et al. High Levels of Immunoglobulin E Autoantibody to 14-3-3 ε Protein Correlate with protection against severe Plasmodium falciparum Malaria. J. Infect. Dis. 2012; 206(11):1781-9.

Ndungu FM, Bull PC, Ross A, Lowe BS, Kabiru E, Marsh K. Naturally acquired immunoglobulin (Ig) G subclass antibodies to crude asexual Plasmodium falciparum lysates: evidence for association with protection for IgG1 and disease for IgG2. Parasite Immunol. 2002; 24: 77–82.

Ofori MF, Dodoo D, Staalsoe T, Kurtzhals JAL, Koram K, Theander TGK et al. Malaria-induced acquisition of antibodies to Plasmodium falciparum variant surface antigens. Infect. Immun. 2002; 70: 2982–2988.

Sim BKL. Delineation of functional regions on Plasmodium falciparum EBA-175 by antibodies eluted from immune complexes. Mol. Biochem. Parasitol. 1998; 95: 183–192.

Patino JAG, Holder AA, McBride JS, Blackman MJ. Antibodies that inhibit malaria merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies. J. Exp. Med. 1997; 186: 1689–1699.

Courtin D, Oesterholt M, Huismans H, Kusi K, Milet J, Badaut C, et al. The quantity and quality of African children's IgG responses to merozoite surface antigens reflect protection against Plasmodium falciparum malaria. PLoS ONE. 2009; 4: e7590.

Theisen M, Roefen W, Singh SK, Andersen G, Amoah L, van de Vegte Bolmer M, et al. A multi-stage malaria vaccine candidate targeting both transmission and asexual parasite life-cycle stages. Vaccine. 2014; 32:2623–30.

Perlmann PE, Perlmann H, Looareesuwan S, Krudsood SR, Kano SH, Matsumoto YO, et al. Contrasting functions of IgG and IgE antimalarial antibodies in uncomplicated and severe Plasmodium falciparum malaria. Am. J. Trop. Med. Hyg. 2000; 62(3):373-7.

Pate MB, Smith JK, Chi DS, Krishnaswamy G. Regulation and dysregulation of immunoglobulin E: a molecular and clinical perspective. Clin. Mol. Allergy. 2010; 8(1):1-3.

Leoratti FM, Durlacher RR, Lacerda MV, Alecrim MG, Ferreira AW, Sanchez MC, Moraes SL. Pattern of humoral immune response to Plasmodium falciparum blood stages in individuals presenting different clinical expressions of malaria. Malar. J. 2008;7(1):1-1.

Kumsiri R, Troye-Blomberg M, Pattanapanyasat K, Krudsood S, Maneerat Y. IgE low affinity receptor (CD23) expression, Plasmodium falciparum specific IgE and tumor necrosis factor-alpha production in Thai uncomplicated and severe falciparum malaria patients. Acta Trop. 2016; 154:25-33.

Aina OO, Agomo CO, Olukosi YA, Okoh HI, Iwalokun BA, Egbuna KN, et al. Malariometric survey of Ibeshe community in Ikorodu, Lagos State: dry season. Malar. Res. Treat. 2013; 487:250. doi: 10.1155/2013/487250.

WHO. Basic Laboratory Methods in Medical Parasitology. 1991. World Health Organization Geneva 12.

Nwaneli EI, Eguonu I, Ebenebe JC, Osuorah CD, Ofiaeli OC, Nri-Ezedi CA. Malaria prevalence and its sociodemographic determinants in febrile children-a hospital-based study in a developing community in South-East Nigeria. J Prev Med Hyg. 2020; 61(2): E173.

Oyibo W, Ntadom G, Uhomoibhi P, Oresanya O, Ogbulafor N, Ajumobi O, et al. Geographical and temporal variation in reduction of malaria infection among children under 5 years of age throughout Nigeria. BMJ Glob. Health. 2021; 6(2): e004250.

Ejezie GC and Ezedinachi EN. Malaria parasite density and body temperature in children under 10 years of age in Calabar, Nigeria. Trop Geogr Med. 1992; 44 (1-2): 97 -101.

Källander, K., Nsungwa-Sabiiti, J. and Peterson, S. Symptoms overlap for malaria and pneumonia-policy implications for home management strategies. Acta Trop. 2004; 90(2): 211-214.

Berkley JA, Maitland K, Mwangi I, Ngetsa C, Mwarumba S, Lowe BS et al. Use of clinical syndromes to target antibiotic prescribing in seriously ill children in malaria endemic area: observational study. BMJ. 2005; 330 (7498): 995–999.

Oladosu OO, Oyibo WA. Overdiagnosis and overtreatment of malaria in children that presented with fever in Lagos, Nigeria. Int. Sch. Res. Notices. 2013; 2013.

Gosling KM, Goodnow CC, Verma NK, Fahrer AM. Defective T-cell function leading to reduced antibody production in a kleisin-beta mutant mouse. Immunology. 2008; 125 (2): 208-217.

English M, Reyburn H, Goodman C, Snow RW. Abandoning presumptive antimalarial treatment for febrile children aged less than five years-a case of running before we can walk. PLoS Medicine. 2009; 6 (1). e1000015.

Federal Ministry of Health – National Malaria Elimination Programme (FMOH-NMEP). National guidelines for diagnosis and treatment of malaria. 2015. 3rd Edition Federal Ministry of Health

Eze EM and Christian SG. Immunoglobulin levels in Plasmodium falciparum malaria infected subjects in Port Harcourt, Nigeria. Int. J. Adv. Multidiscip. Res. 2016; 3(5): 49-55.

Elhussein AB, Mohammedsalih KA, Babikr WG, Fadlelseed OE, Alfadol SM, Naeem A et al. role of serum circulatory IgE and TNF-α And Interleukin 4- 590C/T polymorphism in Sudanese children with severe Falciparum malaria. Int J Microbiol Curr Res. 2019; 11(11): 7986-7992.

Kumsiri, R., Troye-Blomberg, M., Pattanapanyasat, K., Krudsood, S., and Maneerat, Y. 2016. IgE low affinity receptor (CD23) expression, Plasmodium falciparum specific IgE and tumor necrosis factor-alpha production in Thai uncomplicated and severe falciparum malaria patients, Acta Trop154, 25-33.

Kelechi NC, Ositadinma IM, Isaac NN, et.al. Selected immunoglobulins (IgA, IgG, IgM) and lambda free light chain levels in persons with HIV-malaria co-infection. Int J Health Sci Res. 2020; 10(3):134-144.

Yamman-Usman HA, Omalu CI, Abubakar A, Abolarinwa SO, Eke SS, Otuu AC. Seroprevalence of Immunoglobulin IgG antibody response to Plasmodium falciparum merozoite antigens among children in Minna, North Central, Nigeria. Innovare J. Med. Sci. 2021; 9(3): 31-35.

Bouharoun-Tayour H, Attanath P, Sabchareon A, Chongsuphajaisiddhi T, Druilhe P. Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J. Exp. Med. 1990; 172(6): 1633-1641.

Nmorsi OP, Ukwandu NC, Isaac C, Ekoma NE, Asibor V. Immunoglobulin profile of Nigerian children with Plasmodium falciparum infection. Afr. J. Biotechnol. 2008; 7(2).

Nazareth R, Horumpende P, Sonda T, Ndaro A, Mollel E, Paul E, et al. Naturally acquired antibody responses to a synthetic malaria antigen AS202. 11. J. Trop. Med. 2017; 12: 2017.

Idris ZM, Chan CW, Kongere J, Hall T, Logedi J, Gitaka J, Drakeley C, Kaneko A. Naturally acquired antibody response to Plasmodium falciparum describes heterogeneity in transmission on islands in Lake Victoria. Sci. Rep. 2017;7(1):1-3.

Perlmann P, Perlmann H, ElGhazali G, Blomberg MT. IgE and tumor necrosis factor in malaria infection. Immunol. Lett. 1999; 65(1-2):29-33.

Desowitz R, Elm J, Alpers M. Plasmodium falciparum specific immunoglobulin G (IgG), IgM, and IgE antibodies in paired maternal-cord sera from East Sepik Province, Papua New Guinea. Infect Immun 1993; 61: 988–993.

Maeno Y, Steketee R, Nagatake T, Tegoshi T, Desowitz R,Wirima J, et al. Immunoglobulin complex deposits in Plasmodium falciparum-infected placentas from Malawi and Papua New Guinea. Am J Trop Med Hyg. 1993; 49: 574–580.

Cheesbrough M. Packed cell volume and red cell indices, Haematological tests. In District Laboratory Practice in Tropical Countries. 2nded update. Cape Town, South Africa. Cambridge University press 2010; Part 2: 309-313.

Abdalla SH. Red cell associated IgG in patients suffering from Plasmodium falciparum malaria. Br. J. Haematol. 1986; 62(1): 13-19.

Lyke KE, Burges R, Cissoko Y, Sangare L, Dao M, Diarra I, et al. Serum levels of the proinflammatory cytokines interleukin-1 beta (IL-1beta), IL-6, IL-8, IL-10, tumor necrosis factor alpha and IL-12 (p70) in Malian children with severe Plasmodium falciparum malaria and matched uncomplicated malaria or healthy controls. Infect. Immun. 2004; 72: 5630 – 5637.